Medicinal Plants-fabricated AgNPs and Their Role as an Antibacterial Agent against Drug-resistant Uro-pathogens

Antibacterial resistance among uro-pathogens has become a global issue for bacterial infection treatment. The antibacterial activity of various plant extracts and silver nanoparticles (AgNPs) derived from medicinal plant extract was evaluated against different drug-resistant uro-pathogens isolated from clinical patients by Agar Well Diffusion and Minimum Inhibitory Concentration (MIC) assays. A total of 100 urine samples were collected from patients admitted to the hospital followed by the identification of Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Proteus mirabilis, Enterobacter aerogenes, and Klebsiella pneumonia through colony morphology, gram staining, and biochemical characterization. All isolates were highly resistant to all the tested drugs except Amikacin, Gentamicin, and Imipenem. Organic extracts of clove have potent antibacterial activity against all drug-resistant isolates. Interestingly P. aeruginosa was sensitive to all inorganic extracts. These results revealed that the organic extracts of medicinal plants showed more consistent antimicrobial activity compared to their aqueous fraction. Furthermore, the green synthesis of AgNPs derived from clove extract showed strong activity against all tested pathogens followed by green synthesis of AgNPs derived from garlic, ginger, kalwonji, turmeric, and thymus extract respectively compared to medicinal plant extract. Moreover, MIC results showed that AgNPs derived from medicinal plant extract indicate higher efficiency in inhibiting bacterial growth than the medicinal plant extract. The current finding shows that AgNPs derived from plant extract can be recommended as a good alternative for treating the resistant uro-pathogens strains as compared to synthetic drugs and will be considered an attractive candidate for future biological applications.